Who can make the required statement regarding the “Sequence Listing” and CRF?

The required statement regarding the information contained in the “Sequence Listing” and the separate Computer Readable Form (CRF) can be made by specific individuals. According to MPEP 2422.06: “Such a statement may be made by a registered practitioner, the applicant, an inventor, or the person who actually compares the sequence data on behalf of the…

Read More

What is the requirement for submitting a separate computer readable form (CRF) of a “Sequence Listing”?

When a separate computer readable form (CRF) of a “Sequence Listing” is submitted in certain patent applications, a statement regarding the information contained in the “Sequence Listing” and the separate CRF is required. Specifically: For applications filed under 35 U.S.C. 111(a) or national stage applications submitted under 35 U.S.C. 371, where the “Sequence Listing” is…

Read More

What is the scope of the USPTO’s determination in a supplemental examination request?

The scope of the USPTO’s determination in a supplemental examination request is generally limited to the specific items of information and claims identified in the request. According to MPEP 2816: “The determination of whether such an item of information raises a SNQ will generally be limited to a review of the item(s) of information identified…

Read More

Who is responsible for determining if a supplemental examination request is compliant?

The responsibility for determining if a supplemental examination request is compliant lies with the Central Reexamination Unit (CRU) of the United States Patent and Trademark Office (USPTO). The MPEP states: If the Central Reexamination Unit (CRU) determines that the request, as originally submitted, does not satisfy all of the requirements of 37 CFR 1.605, 1.610…

Read More